A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents
Clinical trial NCT05169008 · TERMINATED
Trial details
- NCT number
- NCT05169008
- Sponsor
- CanSino Biologics Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-25
- Primary completion
- 2023-01-13
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.